NCT05186402

Completed

Predictive Factors of Morbidity and Mortality and Overall Su...

Sylvestre KABURA Source

Compare

Other study identifiers

Sponsor study identifier

SKAHM2022

Study Type

observational

Actual enrollment (reported)

80

Locations

0 countries

Sites

N/A

Timeline

Study Start

January 1, 2016

Actual (reported)

Primary Completion

December 31, 2018

Actual (reported)

Study Completion

December 31, 2018

Actual (reported)

Brief Summary

This is a retrospective study extending over a period of three years concerning patients with gastric adenocarcinoma hospitalized in the digestive cancer surgery and liver transplant service of the IBN ROCHD University Hospital Center in Casablanca. Evaluation from a series of 80 cases of gastric adenocarcinomas, follow-up to determine the prognostic factors influencing mortality, morbidity and survival.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 80 participants
Study completion date: December 31, 2018
Actual (reported)
Listed locations: 0 countries · 0 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 1, 2016
Actual (reported)
Primary Completion
December 31, 2018
Actual (reported)
Study Completion
December 31, 2018
Actual (reported)
First Submitted
December 27, 2021
Actual (reported)
First Posted
January 11, 2022
Actual (reported)

Last Updated: January 11, 2022
Status Verified: December 2021
Last Update Submitted: January 10, 2022

Conditions

Gastric Cancer Mortality of Gastric Cancer Overall Survival of Patients With Gastric Cancer

Keywords

gastric cancer mortality, gastric cancer treatment

Outcome Measures

Primary Outcomes (1)

Overall survival
An overall survival of patients treated for gastric cancer
30 months

Interventions

Total or subtotal gastrectomyProcedure

Gastric resection with digestive continuity according Roux or Bilroth

Also known as: Adjuvent chemotherapy

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age15 Years+

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

The study enrolled all the patients who underwent gastric resection for gastric adenocarcinoma

You may qualify if:

patients with gastric cancer

You may not qualify if:

Sponsors & Collaborators

Sylvestre KABURA
Otherlead

MeSH Terms

Conditions

Stomach Neoplasms

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach Diseases

Enrollment

80 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE ONLY
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR INVESTIGATOR
PI Title: Principal investigator

Study Record Dates

First Submitted

December 27, 2021

First Posted

January 11, 2022

Study Start

January 1, 2016

Actual (reported)

NCT02525237

Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric Cancer

Phase 2Unknown

NCT04338438

Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer

Phase 2Completed

NCT02496273

Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer

Phase 1Active Not Recruiting

NCT04340440

Curative D2 vs D1 Lymphadenectomy in Operable Gastric Carcinoma

Not ApplicableCompleted

NCT05999019

Intraoperative Adverse Events in Robotic Radical Gastrectomy for Gastric Cancer

Completed

NCT02748551

A Comparison Laparoscopic With Open Gastric Cancer Surgery for Locally Advanced Gastric Cancer

Phase 3Unknown

patients with benign tumors or other pathologies requiring gastric resection

Contact the study team to confirm eligibility.

Primary Completion

December 31, 2018

Actual (reported)

Study Completion

December 31, 2018

Actual (reported)

Last Updated

January 11, 2022

Record last verified: 2021-12

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT05186402
Data provider: ClinicalTrials.gov
Source updated: 2022-01-11
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:28:28 UTC

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

Source record